Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.37 |
| ▸ | TLR4 | O00206 | 3/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA4 | P22748 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL374935 | 1.00 | MAPK1 (0.47) | MAPK1MCL1KDM4EHSD17B10CYP1A2 | |
| SCHEMBL31276435 | 1.00 | MAPK1 (0.47) | MAPK1MCL1KDM4EHSD17B10CYP1A2 | |
| SCHEMBL31198171 | 0.98 | MAPK1 (0.46) | MAPK1MCL1KDM4EHSD17B10CYP1A2 | |
| SCHEMBL20303983 | 0.94 | MAPK1 (0.54) | MAPK1MCL1KDM4EHSD17B10CYP1A2 | |
| SCHEMBL3171 | 0.94 | MAPK1 (0.54) | MAPK1MCL1KDM4EHSD17B10CYP1A2 | |
| SCHEMBL7305358 | 0.94 | MAPK1 (0.54) | MAPK1MCL1KDM4EHSD17B10CYP1A2 | |
| SCHEMBL6248372 | 0.92 | MAPK1 (0.53) | MAPK1MCL1KDM4EHSD17B10CYP1A2 | |
| SCHEMBL7199566 | 0.92 | MAPK1 (0.53) | MAPK1MCL1KDM4EHSD17B10CYP1A2 | |
| SCHEMBL1615850 | 0.92 | MAPK1 (0.53) | MAPK1MCL1KDM4EHSD17B10CYP1A2 | |
| SCHEMBL3767660 | 0.92 | MAPK1 (0.53) | MAPK1MCL1KDM4EHSD17B10CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1257 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025131772-A1 | HARDENER SYSTEM FOR RADICALLY HARDENING REACTIVE RESINS USED IN CHEMICAL FASTENING | HILTI AKTIENGESELLSCHAFT (LI) | 2025-06-26 | — | — | WO | claimed |
| EP-4574853-A1 | HARDENER SYSTEM FOR RADICALLY HARDENING REACTIVE RESINS USED IN CHEMICAL FASTENING | Hilti Aktiengesellschaft (LI) | 2025-06-25 | — | — | EP | claimed |
| CN-119019250-A | 2- (4- (1-Carboxyethyl) benzyl) adipic acid and preparation method thereof | 北京茗泽中和药物研究有限公司 | 2024-11-26 | — | — | CN | claimed |
| CN-118084640-A | Preparation method of metconazole key intermediate 5- (4-chlorophenyl) methyl-2, 2-dimethylcyclopentanone | 临海市建新化工有限公司 | 2024-05-28 | — | — | CN | claimed |
| US-20240158606-A1 | In-Situ Generation of Nucleating Agents for Indicating Devices | JP LABORATORIES, INC. | 2024-05-16 | — | — | US | claimed |
| CN-117466724-A | Preparation method of 2-amyl-2-cyclopentene-1-ketone | 浙江工业大学 | 2024-01-30 | — | — | CN | claimed |
| CN-113396133-B | Multicomponent composition for producing polyurethane/urea cement mixed systems | SIKA技术股份公司 | 2023-09-22 | — | — | CN | claimed |
| CN-113004133-B | Preparation method of 2, 2-dimethyl cyclopentanone | 九江德思光电材料有限公司 | 2023-06-30 | — | — | CN | claimed |
| CN-115974673-A | Novel synthesis method of loxoprofen acid | 上海奥萝拉医药科技有限公司 | 2023-04-18 | — | — | CN | claimed |
| CN-111995586-B | Synthetic method of agricultural herbicide | 蚌埠学院 | 2023-03-21 | — | — | CN | claimed |
| CN-103333070-B | Preparation method of cyclopentanone-2-carboxylic acid methyl ester | NANTONG TAITONG CHEMICAL TECHNOLOGY CO LTD | 2015-01-07 | — | — | CN | claimed |
| CN-103333070-A | Preparation method of cyclopentanone-2-carboxylic acid methyl ester | NANTONG TAITONG CHEMICAL TECHNOLOGY CO LTD | 2013-10-02 | — | — | CN | claimed |
| CN-102633345-A | Method for treating high-concentration ammonia nitrogen in coal chemical wastewater | CHANGZHOU YAHUAN ENVIRONMENTAL PROT TECHNOLOGY CO LTD | 2012-08-15 | — | — | CN | claimed |
| US-8163195-B2 | Additives for electrolyte solution and electrolyte solution | OTSUKA CHEMICAL CO., LTD. (JP) | 2012-04-24 | — | — | US | claimed |
| US-20100297457-A1 | (Meth) acrylate composition featuring reduced oxygen inhibition | SIKA TECHNOLOGY AG (CH) | 2010-11-25 | — | — | US | claimed |
| US-20090309060-A1 | Additives for Electrolyte Solution and Electrolyte Solution | OTSUKA CHEMICAL CO., LTD. (JP) | 2009-12-17 | — | — | US | claimed |
| CN-101479818-A | Additive for electrolyte and electrolyte | OTSUKA CHEMICAL CO LTD (JP) | 2009-07-08 | — | — | CN | claimed |
| EP-2037468-A1 | ADDITIVE FOR ELECTROLYTE SOLUTION AND ELECTROLYTE SOLUTION | Otsuka Chemical Co., Ltd. (JP) | 2009-03-18 | — | — | EP | claimed |
| CN-101198660-A | (Meth)acrylate composition featuring reduced oxygen inhibition | SIKA TECHNOLOGY AG (CH) | 2008-06-11 | — | — | CN | claimed |
| CN-1468847-A | Closed polyisocyanic acid ester | — | 2004-01-21 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090309060-A1 | Additives for Electrolyte Solution and Electrolyte Solution | SLC9A1, SLC26A3, AQP1 | MAPK1 488/4885MCL1 3882/4885KDM4E 1133/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.